Well this is a bummer! So much for Stenocare and t
Post# of 15624
(Total Views: 760)
Posted On: 12/22/2019 7:46:19 AM
Well this is a bummer! So much for Stenocare and the MOU with OWC. Mind you I never thought it would amount to anything. Stenocare has found a new partner and they are saying thanks but no thanks to OWC.
https://news.cision.com/stenocare/r/stenocare...a,c2995690
Quote:
Strategic focus
The negotiations and explorations with Solural has been underway for some time and represents a prime opportunity that closely align with STENOCAREs focus upon development and delivery of next generation prescription-based medical cannabis. The Solural strategic partnership is unique, highly attractive and very tangible. For that reason, STENOCAREs has decided to devote a large part of its development resources and budgets to this partnership. As a consequence, and to avoid defocus from this important project, STENOCARE will not further pursue the potential working relationship with OWC Pharmaceutical Research (Israel). Therefore, STENOCARE and OWC have agreed not to proceed with finalizing an agreement based on the previously announced Memorandum of Understanding.
The difference here is that STENOCARE and Solural Pharma Aps have signed a strategic Partnership Agreement, not just a MOU. Furthermore Solural is also a Danish company.
Apparently "negotiations and explorations with Solural has been underway for some time". Really? Was it not just about a month ago that they were supposedly exploring a relationship with someone else? It makes you wonder how committed these guys really are.
Maybe I should send my friend Thomas another email to let him know I was only kidding about OWC. Oh well, nothing ventured nothing gained!
https://news.cision.com/stenocare/r/stenocare...a,c2995690
Quote:
Strategic focus
The negotiations and explorations with Solural has been underway for some time and represents a prime opportunity that closely align with STENOCAREs focus upon development and delivery of next generation prescription-based medical cannabis. The Solural strategic partnership is unique, highly attractive and very tangible. For that reason, STENOCAREs has decided to devote a large part of its development resources and budgets to this partnership. As a consequence, and to avoid defocus from this important project, STENOCARE will not further pursue the potential working relationship with OWC Pharmaceutical Research (Israel). Therefore, STENOCARE and OWC have agreed not to proceed with finalizing an agreement based on the previously announced Memorandum of Understanding.
The difference here is that STENOCARE and Solural Pharma Aps have signed a strategic Partnership Agreement, not just a MOU. Furthermore Solural is also a Danish company.
Apparently "negotiations and explorations with Solural has been underway for some time". Really? Was it not just about a month ago that they were supposedly exploring a relationship with someone else? It makes you wonder how committed these guys really are.
Maybe I should send my friend Thomas another email to let him know I was only kidding about OWC. Oh well, nothing ventured nothing gained!
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼